CAVAN JOHN T (CFO) purchased 208.3% of their position (10K shares) of HEPION PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $20.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/18/2021ACC: 0001104659-21-025196
Officer· CFO
Since Jul 2018
+10K
Net shares
Net buyer
$20.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
10K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10K
Price / share
$2.00
Trade value
$20K
% of position
208.3%
2/18/2021
4.80K→14.80K
Total
Net shares
+10K
Net value
$20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2021 | P · Purchase | +10K | $2.00 | $20K | 208.3% | 4.80K | 14.80K |
| Total | +10K | $20K | ||||||
Derivative Transactions0
No derivative transactions reported